3: Initial statement of beneficial ownership of securities-Director Shoemaker Stephen H
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
3: Initial statement of beneficial ownership of securities-Director Goodman Jay Lawrence
SC 13G: Statement of acquisition of beneficial ownership by individuals-Sir Marc Feldmann(8.6%)
180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Jordan Blair
180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Smith Ryan Lewis
180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director JIMENEZ OMAR
180 Life Sciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Feldmann Marc
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Feldmann Marc
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Woody James N.
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Feldmann Marc
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director RAY RUSSELL T
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director DeLuca Teresa
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Woody James N.
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Francis Knuettel II
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Rothbard Jonathan B.
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director STEINMAN LAWRENCE
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Gold Lawrence Marshall
180 Life Sciences | 4: Statement of changes in beneficial ownership of securities-CFO Pamir Ozan